ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

VANI vs ELMD // GROSS PROFIT MARGIN

Vivani Medical Inc. (NASDAQ) VS. Electromed Inc. (NYSE) • 15-METRIC TALLY: VANI 1 — ELMD 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VANI VS. ELMD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC VANI ELMD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 78.10% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 24.10% -59.10 ELMD /roic <GO>
EV/EBITDA & P/E Valuation — 21.8x — TIE /valuation <GO>
Free Cash Flow Yield -24.79% 4.85% -29.64 ELMD /fcf-yield <GO>
Operating Margin — 15.10% — TIE /operating-margins <GO>
Net Profit Margin — 11.80% — TIE /net-margins <GO>
Revenue Growth (YoY) — 17.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 17.64 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 ELMD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.0 48.8 -3.80 ELMD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 3.6x 25.5x -21.90 VANI /forward-pe <GO>
Enterprise Scale & Market Cap $102.8M $229.4M -$126.6M ELMD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR VANI REV ELMD REV VANI GROSS % ELMD GROSS % VANI FCF ELMD FCF
FY 2025 $0 $64.0M — 78.1% -$25.5M $11.1M
FY 2024 $0 $54.7M — 76.3% -$21.3M $8.8M
FY 2023 $0 $48.1M — — -$23.7M $1.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VANI // BETA —
ELMD // BETA —